BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33868165)

  • 41. Use of recombinant human growth hormone in children with thalassemia.
    Geffner ME; Karlsson H
    Horm Res; 2009 Jan; 71 Suppl 1():46-50. PubMed ID: 19153505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
    Janssen YJ; Hamdy NA; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The effect of one year therapy with recombinant human growth hormone (rhGH) on growth velocity, calcium-phosphorus metabolism, bone mineral density and changes in body composition in children with growth hormone deficiency (GHD)].
    Zak T; Basiak A; Zubkiewicz-Kucharska A; Noczyńska A
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):39-43. PubMed ID: 20529605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of the peripheral sensitivity to growth hormone in adults with GH deficiency.
    Aimaretti G; Fanciulli G; Bellone S; Maccario M; Arvat E; Delitala G; Camanni F; Ghigo E
    Eur J Endocrinol; 2001 Sep; 145(3):267-72. PubMed ID: 11517006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Recombinant human growth hormone treatment in short children with renal disease--our first experience].
    Spasojević-Dimitrijeva B; Kostić M; Peco-Antić A; Kruscić D; Cvetković M; Milosevski-Lomić G; Paripović D
    Srp Arh Celok Lek; 2010; 138(3-4):197-203. PubMed ID: 20499500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating asymmetric dimethylarginine and lipid profile in pre-pubertal children with growth hormone deficiency: effect of 12-month growth hormone replacement therapy.
    De Marco S; Marcovecchio ML; Caniglia D; De Leonibus C; Chiarelli F; Mohn A
    Growth Horm IGF Res; 2014 Oct; 24(5):216-20. PubMed ID: 25172154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of long-term recombinant growth hormone therapy in children--the National Cooperative Growth Study, USA, 1985-1994.
    Root AW; Kemp SF; Rundle AC; Dana K; Attie KM
    J Pediatr Endocrinol Metab; 1998; 11(3):403-12. PubMed ID: 11517956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gender-Dependent Growth and Insulin-Like Growth Factor-1 Responses to Growth Hormone Therapy in Prepubertal Growth Hormone-Deficient Children.
    Witkowska-Sędek E; Rumińska M; Majcher A; Pyrżak B
    Adv Exp Med Biol; 2019; 1133():65-73. PubMed ID: 30338487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
    Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased testicular insulin-like growth factor 1 is associated with gonadal activation by recombinant growth hormone in immature rats.
    Xu Y; Han CY; Park MJ; Gye MC
    Reprod Biol Endocrinol; 2022 Apr; 20(1):72. PubMed ID: 35459135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of long-term growth hormone therapy in short non-growth hormone-deficient children.
    Schena L; Meazza C; Pagani S; Paganelli V; Bozzola E; Tinelli C; Buzi F; Bozzola M
    J Pediatr Endocrinol Metab; 2017 Feb; 30(2):197-201. PubMed ID: 28099132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
    Esen I; Demirel F; Tepe D; Kara O; Koc N
    Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
    Richmond E; Rogol AD; Basdemir D; Veldhuis OL; Clarke W; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
    Pfäffle R
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determinants of Final Height in Patients Born Small for Gestational Age Treated with Recombinant Growth Hormone.
    Adler E; Lambert AS; Bouvattier C; Thomas-Teinturier C; Rothenbuhler A; de Boissieu P; Linglart A
    Horm Res Paediatr; 2021; 94(1-2):52-62. PubMed ID: 34182561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of recombinant human growth hormone on linear growth in children with Crohn's disease and short stature.
    Wong SC; Hassan K; McGrogan P; Weaver LT; Ahmed SF
    J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1315-24. PubMed ID: 18341091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two years of replacement therapy in adults with growth hormone deficiency.
    Verhelst J; Abs R; Vandeweghe M; Mockel J; Legros JJ; Copinschi G; Mahler C; Velkeniers B; Vanhaelst L; Van Aelst A; De Rijdt D; Stevenaert A; Beckers A
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):485-94. PubMed ID: 9404448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of recombinant human growth hormone (GH) replacement therapy on bone metabolism in children with GH deficiency].
    Li Y; Chen LQ; Liang L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 34(4):312-5. PubMed ID: 16059977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Final height in non-growth hormone deficient children treated with growth hormone. The Italian Multicentre Study Group.
    Bernasconi S; Street ME; Volta C; Mazzardo G
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):261-6; discussion 267. PubMed ID: 9373443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.